1. Qin, Xiaodan, Sun, Huiling, Hu, Shangshang, Pan, Yuqin, Wang, Shukui. 2024. A hypoxia-glycolysis-lactate-related gene signature for prognosis prediction in hepatocellular carcinoma. In BMC medical genomics, 17, 88. doi:10.1186/s12920-024-01867-x. https://pubmed.ncbi.nlm.nih.gov/38627714/
2. Li, Jieling, Zhou, Liyuan, Liu, Ying, Wang, Xiao, Wang, Shaoxiang. 2021. Comprehensive Analysis of Cyclin Family Gene Expression in Colon Cancer. In Frontiers in oncology, 11, 674394. doi:10.3389/fonc.2021.674394. https://pubmed.ncbi.nlm.nih.gov/33996604/
3. Gu, Changhao, Jin, Lulu, Lv, Xiaoyan, Wen, Congle, Su, Xiuxiu. 2024. Development and validation of a prognostic model for colon cancer based on mitotic gene signatures and immune microenvironment analysis. In Discover oncology, 15, 535. doi:10.1007/s12672-024-01421-2. https://pubmed.ncbi.nlm.nih.gov/39382813/
4. Viet, Chi T, Yu, Gary, Asam, Kesava, Allen, Clint T, Aouizerat, Bradley E. 2021. The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma. In Biomarker research, 9, 42. doi:10.1186/s40364-021-00292-x. https://pubmed.ncbi.nlm.nih.gov/34090518/